Cat. No.: X23-10-ZQ870
ERK inhibitor XMD8-92, Purity ≥98%
Synonym: XMD8-92; 1234480-50-2; XMD 8-92; 2-[[2-Ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-B][1,4]benzodiazepin-6-one; 2-{[2-Ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl]amino}-5,11-dimethyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one; ERK inhibitor
- MDL: MFCD18782742
- CAS Number: 1234480-50-2
- Compound CID: 46843772
Product Size
25 mg; 50 mg; 100 mg
Properties
Description
XMD8-92, soluble in warmed DMSO and insoluble in water and ethanol, exhibits potent inhibition of ERK kinase. It targets ERK5.
Molecular Formula
C26H30N6O3
Solubility
Warmed DMSO: 70 mg/mL (147.5 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
XMD8-92 can be used to investigate the effects of ERK5 inhibition in cellular signaling and cancer research.
Related Products
